NCT06441747 Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP) Status RECRUITING Phase PHASE2
NCT06440993 Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT06435273 Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma Status COMPLETED Phase PHASE2
NCT06432764 Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease. Status COMPLETED Phase PHASE1
NCT06429761 Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients Status RECRUITING Phase PHASE4
NCT06422689 Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06422676 MultIceNtre Non-intERVentional Study for Efficacy,Safety Evaluation of BREZTRI in Pts With COPD in RussiA Status COMPLETED Phase N/A
NCT06422663 A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China Status COMPLETED Phase N/A
NCT06419413 A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population Status RECRUITING Phase N/A
NCT06419179 Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC) Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06417814 A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06417801 Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer. Status RECRUITING Phase N/A
NCT06414746 Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia Status COMPLETED Phase N/A
NCT06406400 Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2). Status TERMINATED Phase PHASE1
NCT06388616 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone Status COMPLETED Phase PHASE1
NCT06386263 HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada Status COMPLETED Phase N/A